The Alliance’s fifth annual Presidency conference, to be held once again at the historic Bibliothèque Solvay in Brussels on 28 March, will build on solid foundations and aim to raise awareness among policymakers about the needs of modern-day patients and how personalised medicine has the potential to change healthcare for the better.

The theme for the fifth conference will be: “Innovation and Screening in Lung Cancer - The Future.”

This year’s conference focus will be on lung cancer screening. Figures show that lung cancer causes almost 1.4 million deaths each year worldwide, representing almost one-fifth of all cancer deaths.

Within the EU, meanwhile, lung cancer is also the biggest killer of all cancers, responsible for almost 270,000 annual deaths (some 21%).

EAPM is of the view that preventative measures need to be boosted across Europe, whether through better information for patients, bigger screening programmes and improved diagnostic tools that are available to all citizens regardless of where they live and their financial status.

Speakers at this year’s conference are expected to include several cross-party MEPs, Ministers plus representatives from the European Commission, various Member States and industry, patient representatives and media.